Bcl-2 and GDNF delivered by HSV-Mediated Gene Transfer Act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration
Bcl-2 and GDNF delivered by HSV-Mediated Gene Transfer Act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration
复制标题
DOI:
10.1006/exnr.2001.7671
复制
发表时间:
2001-06-01
影响因子:
5.3
通讯作者:
Fink, DJ
中科院分区:
文献类型:
--
作者:
Natsume, A;Mata, M;Fink, DJ
Previous studies have demonstrated that either the neurotrophin glial-derived neurotrophic factor (GDNF) or the antiapoptotic peptide Bcl-2 delivered into striatum by a viral vector protects dopaminergic neurons of the substantia nigra in vivo from degeneration induced by the administration of the neurotoxin g-hydroxydopamine (6-OHDA), In this study we used recombinant, replication-incompetent, genomic herpes simplex virus-based vectors to deliver the genes coding for Bcl-2 and GDNF into rat substantia nigra (SN) 1 week prior to 6-OHDA injection into the striatum. Vector-mediated expression of either Bcl-2 or GDNF alone each resulted in a doubling in cell survival as measured by retrograde labeling with fluorogold (FG) and a 50% increase in tyrosine hydroxylase-immunoreactive (TH-IR) neurons in the lesioned SN compared to the unlesioned side. Gene transfer of Bcl-2 and GDNF were equivalent in this effect. Coadministration of the Bcl-2-expressing vector with the GDNF-expressing vector improved the survival of lesioned SN neurons as measured by FG labeling by 33% and by the expression of TH-IR by 15%. These results suggest that the two factors delivered together act in an additive fashion to improve DA cell survival in the face of 6-OHDA toxicity. (C) 2001 Academic Press.